Maple Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Maple Capital Management, Inc.

$1.23 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $14,585 - $16,537	-304 Reduced 5.43%	5,299 $287,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $33,305 - $39,742	-687 Reduced 10.92%	5,603 $287,000
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $40,059 - $44,793	692 Added 12.36%	6,290 $365,000
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $9,556 - $10,611	-150 Reduced 2.61%	5,598 $357,000
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $28,386 - $32,196	-432 Reduced 6.99%	5,748 $398,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $7,190 - $8,514	105 Added 1.73%	6,180 $444,000
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $3 - $2,151	-28 Reduced 0.46%	6,075 $464,000
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $7,262 - $7,998	-100 Reduced 1.61%	6,103 $469,000
Q1 2022 May 17, 2022	SELL	$61.48 - $73.72 $93,080 - $111,612	-1,514 Reduced 19.62%	6,203 $453,000
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $75,082 - $87,528	-1,400 Reduced 15.36%	7,717 $481,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $8,791 - $9,573	142 Added 1.58%	9,117 $615,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $41,538 - $46,718	-700 Reduced 7.24%	8,975 $567,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $5,774 - $6,543	-100 Reduced 1.02%	9,675 $600,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $39,282 - $43,529	-684 Reduced 6.54%	9,775 $622,000
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $140,558 - $164,326	-2,564 Reduced 19.69%	10,459 $615,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $189,033 - $274,709	-4,074 Reduced 23.83%	13,023 $725,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $497,513 - $648,960	10,110 Added 144.7%	17,097 $1.1 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $11,462 - $13,590	-268 Reduced 3.69%	6,987 $354,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $11,868 - $13,124	-266 Reduced 3.54%	7,255 $329,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $36,096 - $43,040	800 Added 11.9%	7,521 $359,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $12,190 - $15,807	-250 Reduced 3.59%	6,721 $349,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $551 - $622	-10 Reduced 0.14%	6,971 $0
Q4 2017 Feb 15, 2018	SELL	$59.94 - $65.35 $12,107 - $13,200	-202 Reduced 2.81%	6,981 $428,000
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $396,717 - $457,844	7,183	7,183 $458,000

Others Institutions Holding BMY

# of Institutions

2,404

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$10.1 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.6 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.95 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$4.04 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.2 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maple Capital Management, Inc. with notifications on news.

Account